Evaluation of an emergency department buprenorphine (cas 136232-82-1) induction and medication-assisted treatment referral program

Add time:09/02/2019    Source:sciencedirect.com

BackgroundEmergency departments are struggling to manage the increasing number of patients seen for opioid use disorders and opioid overdose. With opioid overdose deaths rising at alarming rates, emergency physicians are beginning to induce patients with long-acting opioids such as buprenorphine (cas 136232-82-1) and referring patients to outpatient medication-assisted treatment facilities. The objective of this study was to describe a pragmatic approach to buprenorphine induction, referral to treatment, and assess follow-up rates.

We also recommend Trading Suppliers and Manufacturers of buprenorphine (cas 136232-82-1). Pls Click Website Link as below: cas 136232-82-1 suppliers

Prev:Full length articleUnderstanding the use of diverted buprenorphine (cas 136232-82-1)
Next:Research Paper“They're making it so hard for people to get help:” Motivations for non-prescribed buprenorphine (cas 136232-82-1) use in a time of treatment expansion)